Differential effects of integrin alpha chain mutations on invasin and natural ligand interaction.
To determine if recognition of the Yersinia pseudotuberculosis invasin protein and natural substrates requires identical integrin residues, a region of the human alpha3 integrin chain predicted to be involved in substrate adhesion was targeted for mutation. One point mutation located in a region of the third N-terminal repeat of the alpha3 chain, alpha3-W220A, failed to promote adhesion to the natural alpha3 beta1 substrate epiligrin but maintained near wild type levels of adhesion to invasin. A second nearby mutation, alpha3-Y218A, which showed no detectable adhesion to epiligrin, was only partially attenuated for invasin binding as well as invasin-mediated bacterial uptake. A third substitution, alpha3-D154A, predicted to be in the second N-terminal repeat not known to be implicated in cell adhesion, was competent for invasin-promoted adhesion events and appeared to encode a receptor of increased activity, as it had a higher efficiency than wild type receptor for adhesion to epiligrin. Cell lines expressing this derivative were not recognized by a function blocking anti-alpha3 antibody, indicating that the second and third repeats of the alpha3 chain are either closely linked in space or the second repeat can modulate activity of the third. Differential effects on substrate adhesion do not appear to be associated with all integrin alpha chain mutations, as alpha4 chain mutations affecting the divalent cation binding domains depressed adhesion to invasin to a significant extent.
Krukonis
E S
ES
Tufts University School of Medicine, Department of Molecular Biology and Microbiology, Boston, Massachusetts 02111, USA.
Dersch
P
P
Eble
J A
JA
Isberg
R R
RR
D018829:Adhesins, Bacterial; D000595:Amino Acid Sequence; D015703:Antigens, CD / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D001422:Bacterial Adhesion / Q000502:physiology*; D001426:Bacterial Proteins / Q000378:metabolism*; D015815:Cell Adhesion Molecules / Q000378:metabolism; D006801:Humans; D039422:Integrin alpha3; D039201:Integrin alpha3beta1; D016023:Integrins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D020014:K562 Cells; D008024:Ligands; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D017354:Point Mutation; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D014162:Transfection; D015011:Yersinia pseudotuberculosis / Q000502:physiology*; D000097794:Kalinin
D018829:Adhesins, Bacterial; D015703:Antigens, CD; D001426:Bacterial Proteins; D015815:Cell Adhesion Molecules; D039422:Integrin alpha3; D039201:Integrin alpha3beta1; D016023:Integrins; D008024:Ligands; D011994:Recombinant Proteins; D000097794:Kalinin; C053476:invasin, Yersinia